Relapsed Acute Myelogenous Leukemia (AML)
1 clinical trials · Condition
◉ Watch Relapsed Acute Myelogenous Leukemia (AML)
| Record | Firm | Date |
|---|---|---|
| Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML (NCT02091245) | Dana-Farber Cancer Institute | 2014-03-01 |
Track Relapsed Acute Myelogenous Leukemia (AML) automatically
Every clearance here is in the API, with alerts when new ones post.